Finch Therapeutics Group, Inc. financial data

Symbol
FNCH on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
75 State Street, Suite 100, Boston, Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 10, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 515 % -8.23%
Debt-to-equity 142 % +134%
Return On Equity -68.1 % +54.2%
Return On Assets -28.1 % +69.7%
Operating Margin -78.4 K % -484%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.61 M shares -96.7%
Common Stock, Shares, Outstanding 1.61 M shares -96.7%
Entity Public Float 9.1 M USD -88%
Common Stock, Value, Issued 2 K USD -95.8%
Weighted Average Number of Shares Outstanding, Basic 1.61 M shares +0.18%
Weighted Average Number of Shares Outstanding, Diluted 1.61 M shares +0.18%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 0 USD -100%
Research and Development Expense 203 K USD -99.5%
General and Administrative Expense 22.5 M USD -38.3%
Operating Income (Loss) -23.3 M USD +85.2%
Nonoperating Income (Expense) 6.99 M USD +669%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -16.3 M USD +89.6%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -16.3 M USD +89.3%
Earnings Per Share, Basic -9.81 USD/shares +91.1%
Earnings Per Share, Diluted -9.81 USD/shares +91.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 20.8 M USD -50.2%
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD -100%
Assets, Current 21.2 M USD -51.2%
Property, Plant and Equipment, Net 551 K USD -55.8%
Operating Lease, Right-of-Use Asset 26 M USD -18.3%
Goodwill 0 USD -100%
Other Assets, Noncurrent 0 USD -100%
Assets 50.1 M USD -36.6%
Accounts Payable, Current 47 K USD -98.2%
Liabilities, Current 3.5 M USD -73.5%
Deferred Income Tax Liabilities, Net 0 USD -100%
Operating Lease, Liability, Noncurrent 27.6 M USD -16.2%
Other Liabilities, Noncurrent 0 USD -100%
Liabilities 31.1 M USD -32.6%
Retained Earnings (Accumulated Deficit) -354 M USD -4.33%
Stockholders' Equity Attributable to Parent 19 M USD -44.9%
Liabilities and Equity 50.1 M USD -36.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -4.36 M USD +67.4%
Net Cash Provided by (Used in) Financing Activities 0 USD
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 200 M shares 0%
Common Stock, Shares, Issued 1.61 M shares -96.7%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -4.36 M USD +85.2%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 23.1 M USD
Interest Paid, Excluding Capitalized Interest, Operating Activities 202 K USD +10000%
Deferred Tax Assets, Valuation Allowance 86.4 M USD +14.3%
Deferred Tax Assets, Gross 102 M USD +14.3%
Depreciation 1.4 M USD +7.69%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Property, Plant and Equipment, Gross 869 K USD -96.6%
Operating Lease, Liability, Current 2.01 M USD -38.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Deferred Income Tax Expense (Benefit) 0 USD
Deferred Tax Assets, Operating Loss Carryforwards 73.7 M USD +19.3%
Unrecognized Tax Benefits 3.57 M USD +44.4%
Preferred Stock, Shares Outstanding 0 shares
Operating Leases, Future Minimum Payments, Due in Two Years 4.93 M USD -21.2%
Depreciation, Depletion and Amortization 43 K USD -96.9%
Operating Leases, Future Minimum Payments Due, Next Twelve Months 3.2 M USD -30%
Deferred Tax Assets, Net of Valuation Allowance 15.6 M USD +14.6%
Share-based Payment Arrangement, Expense 777 K USD -88.7%
Operating Leases, Future Minimum Payments, Due in Three Years 5.07 M USD -21.1%
Operating Leases, Future Minimum Payments Due 40.8 M USD -19.3%